Baseline Frailty Evaluation in Drug Development

J Frailty Aging. 2016;5(3):139-40. doi: 10.14283/jfa.2016.99.

Authors

F Cerreta¹, J Ankri, D Bowen, A Cherubini, A J Cruz Jentoft, A Guðmundsson, M Haberkamp, P Jansen, N Marchionni, S Morgan, E Rönnemaa, M Petrovic, A Pilotto, M Rosa, H Wildiers

Affiliation

¹ Francesca Cerreta, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom; Phone: +44 (0)20 74188400; Fax: +44 (0)20 74188613; email: Francesca.cerreta@ema.europa.eu.

PMID: 27554312
DOI: 10.14283/jfa.2016.99

No abstract available

MeSH terms

Aged
Aged, 80 and over
Clinical Trials as Topic*
Drug Evaluation*
Female
Frail Elderly*
Geriatric Assessment*
Humans
Male
Risk Assessment